A EUROPEAN NETWORK TO PROMOTE HPV VACCINACTION,TO STUDY HPV AWARENESS IN THE NEW EU MEMBER STATES AND TO FACE CERVICAL CANCER.
Human Papilloma Virus is responsible for invasive cervical cancer and among women aged 15-44, it is the second most common cancer after breast one. There are around 33.000 cases of cervical cancer in the EU every year and 15.000 deaths. Within Europe there are wide variations in cervical cancer mortality and incidence rates, closely linked to the existence of a screening programme. In particular, the situation in the new member states is much worse, with incidence and mortality rates that are double those seen in the EU-15. In this framework, AURORA will aim to disseminate and exchange good practices on promotion of HPV vaccination in the New Member States. Furthermore, AURORA will promote cervical screening to fight the cervical cancer spreading in the EU and to reduce its mortality rate. One of the most important AURORA challenge will be to achieve integrated vaccination and screening strategies in a cost-effective way with the maximum benefit for women. AURORA will promote the widest exchange of best practices among country partners by a strong dissemination of its results in order to: • Identify a common and feasible strategy to promote Cervical Cancer Screening (CCS) in the New EU Member States targeting women in the reproductive age (30-69 years old) and ensuring the coverage of the hard to reach groups (according to the demographic or socio-economic definitions: young people, rural people, ethnic groups and minorities). • Assist these States in the implementation of evidence-based population based screening for cervical cancer. • Promote a European exchange of information and expertise (training and education) on the development and implementation of good practices in Cervical Cancer Prevention and Advocacy. AURORA consortium will: • identify and analyse good practices and strategies to promote the CCS. • Train 24 health professionals as Trainers of trainers about how to reach, approach the project target group and to perform the CCS. • Train 12 advocacy leaders in cervical cancer control advocacy able to persuade influential people to stimulate change. • Establish a network of healthcare centers that will test AURORA methodology.